Korio Secures $6.8M in Funding
Summary
The round was led by Excelerate Health Ventures, with participation from Boston Millennia Partners and other investors. The company intends to use the funds to enhance its expansion, to bolster its team, and respond to increasing demand from life sciences and clinical research organizations. Led by CEO Ryan Keane, Korio provides a clinical trial software platform that streamlines processes, and delivers predictable outcomes, all within shorter timeframes. By integrating the insights and expertise of the industry’s subject matter experts into its platform, Korio aims to challenge the status quo of complex, manual processes that have long plagued RTSM providers’ workflow and delivery models.
Funding
Amount
$6.8M
Total raised
Date
October 10, 2023
Announcement date
Investors
-
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected